CORONA, CA – February 1, 2001 – Watson Pharmaceuticals,
Inc. (NYSE: WPI) announced that a live webcast of its presentation
scheduled for Tuesday, February 6, 2001, at 4:10 p.m. E.S.T.
(1:10 p.m. P.S.T.) at the Merrill Lynch Pharmaceuticals Healthcare
Conference at the Grand Hyatt Hotel in New York, NY, may be
accessed via the internet.
The URL for the webcast will be http://events.mlresearchmedia.com/ml/pharmedbio.
On the day of the webcast, this link will have a menu that will
allow any visitor to the website access to Watson’s presentation.
A recording of the webcast may be accessed for three months
after the event at the same URL.
This press release may contain forward-looking
statements relating to Watson’s future business performance,
which involve risks and uncertainties that cannot be predicted
or quantified. Consequently, actual results may differ materially
from those expressed or implied. Such risks and uncertainties
include, among others, those detailed in Watson’s Securities
and Exchange Commission filings.
Watson Pharmaceuticals, Inc., headquartered
in Corona, California, is engaged in the development, manufacture
and sale of proprietary and off-patent pharmaceutical products.
Watson pursues a strategy of generating revenue through established
proprietary and off-patent business, capitalizing on its proven
ability to support the development and commercialization of
a broad range of proprietary and off-patent pharmaceutical products.
This and past press releases of Watson Pharmaceuticals,
Inc. are available at Watson’s web site at www.watsonpharm.com.
In addition, press releases are available through PR Newswire’s
Company On-Call fax service at (800) 758-5804, extension 112856,
and at www.prnewswire.com.
Watson Pharmaceuticals, Inc.
Director, Corporate Communications
Morgen-Walke Associates, Inc.
Jim Byers (Investors)
Christopher Katis (Press)